Townsquare Capital LLC Castle Biosciences Inc Transaction History
Townsquare Capital LLC
- $8.15 Billion
- Q3 2024
A detailed history of Townsquare Capital LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Townsquare Capital LLC holds 23,270 shares of CSTL stock, worth $630,384. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23,270
Previous 18,582
25.23%
Holding current value
$630,384
Previous $404,000
64.11%
% of portfolio
0.01%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding CSTL
# of Institutions
201Shares Held
24.5MCall Options Held
303KPut Options Held
30.3K-
Black Rock Inc. New York, NY3.04MShares$82.5 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.83MShares$49.5 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$47.4 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.26MShares$34.2 Million0.61% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.26MShares$34 Million2.85% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $712M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...